Navigation Links
Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study

fecting our PolyHeme red blood cell substitute product. These forward-looking statements are identified by the use of such terms as "intends," "expects," "plans," "estimates," "anticipates," "should," "believes" and similar terms. These forward-looking statements involve inherent risks and uncertainties. Our actual results may therefore differ materially from those predicted by the forward-looking statements because of various factors and possible events, including the possibility that since the data from our Phase III clinical trial have not been submitted to, or reviewed by, FDA, they may not be sufficient to demonstrate the safety or effectiveness of PolyHeme, our ability to obtain FDA approval to market PolyHeme commercially, our ability to obtain priority review, the availability of capital to finance our clinical trials and ongoing business operations, our ability to obtain adequate supplies of raw materials and to manufacture PolyHeme in commercial quantities, our ability to market PolyHeme successfully, the possibility that competitors will develop products that will render PolyHeme obsolete or non-competitive, our ability to protect our intellectual property rights, the outcome of certain governmental inquiries and purported class action lawsuit as described in our most recently filed annual report on Form 10-K and quarterly report on Form 10-Q, the possibility that we may be subject to product liability claims and other legal actions, our dependency on a limited number of key personnel, the uncertainty of third party reimbursement for our product and other risks and uncertainties described from time to time in our periodic reports filed with the Securities and Exchange Commission, including our most recently filed annual report on Form 10-K and quarterly report on Form 10-Q. These forward-looking statements speak only as of the date of this press release. We do not undertake any obligation to update or publicly release any revisions to forward-looking stat
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Northfield Laboratories Investor Update
2. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
3. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study for Milnacipran as a Treatment for Fibromyalgia Syndrome
4. Columbia Laboratories Reports Preliminary Findings from the Ongoing Data Analysis of the Phase III Clinical Study of PROCHIEVE 8% (progesterone gel) to Prevent Preterm Birth
5. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
6. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
7. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
8. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
9. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
10. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
11. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
Post Your Comments:
(Date:4/21/2015)... April 21, 2015 The saturated European market ... the rising incidence of preterm births. This trend is ... unit (NICU) devices but also skilled and trained professionals ... Frost & Sullivan, Analysis of the Western European Infant ... of $151.5 million in 2014 and estimates this to ...
(Date:4/20/2015)... WASHINGTON , April 21, 2015  Following is ... Bureau: LIFESAVING MEDICINE ... world,s most important medicines — insulin —became available for ... of millions of people suffering from diabetes. Insulin is ... in the processing of carbohydrates in the human body. ...
(Date:4/20/2015)... YORK , April 20, 2015 This report ... by the following Segments: Toxicology Testing (In-Vivo, & In-Vitro), and ... US, Canada , Japan ... , and Rest of World. Annual estimates and forecasts are ... historic analysis is provided for these markets. Market data and ...
Breaking Medicine Technology:Rising Numbers of Preterm Births Stoke Demand for Infant Care Solutions in Europe 2Rising Numbers of Preterm Births Stoke Demand for Infant Care Solutions in Europe 3U.S. Census Bureau Daily Feature for April 21 2World ADME-Toxicology Testing Industry 2World ADME-Toxicology Testing Industry 3World ADME-Toxicology Testing Industry 4World ADME-Toxicology Testing Industry 5World ADME-Toxicology Testing Industry 6World ADME-Toxicology Testing Industry 7World ADME-Toxicology Testing Industry 8World ADME-Toxicology Testing Industry 9World ADME-Toxicology Testing Industry 10World ADME-Toxicology Testing Industry 11World ADME-Toxicology Testing Industry 12World ADME-Toxicology Testing Industry 13World ADME-Toxicology Testing Industry 14World ADME-Toxicology Testing Industry 15World ADME-Toxicology Testing Industry 16World ADME-Toxicology Testing Industry 17World ADME-Toxicology Testing Industry 18World ADME-Toxicology Testing Industry 19
(Date:4/21/2015)... NC (PRWEB) April 21, 2015 A ... survival rates among patients with peritoneal cancers like mesothelioma ... Surviving Mesothelioma has just posted the results of the ... . , Doctors at North Hampshire Hospital in ... with peritoneal malignancies such as mesothelioma between ...
(Date:4/21/2015)... April 21, 2015 Atlantic Information ... launch of Medicare-Medicaid Dual Eligibles Database, a brand-new, ... care provided to the more than 9 million ... for more than $300 billion in annual health ... the same team that also creates the industry-leading ...
(Date:4/21/2015)... Now, busy Diet Doc clients can bolster their metabolism ... breakfast omelets. Like Diet Doc’s other pre-packaged diet meals, ... are delivered directly to their door. Patients can choose from ... only appeal to the taste buds, but ensure that dieters ... low carbohydrate meals. , One of the only medical ...
(Date:4/21/2015)... TX (PRWEB) April 21, 2015 ... is actively involved in various components of breast ... fields. , "Breast reconstruction research continues ... mastectomy. Despite recent advances, many unanswered questions ... provide patients with optimal results," says Dr. Oscar ...
(Date:4/21/2015)... April 21, 2015 The Science Museum of ... special addition to its Lunch Break Science program. On Wednesday, ... Quarks! – taking guests from the subatomic world of quantum ... The Museum invites members of the community to grab lunch ... Lab physicist. Guests will delve into the nucleus and dissect ...
Breaking Medicine News(10 mins):Health News:New Findings Highlight Value of Experience in Peritoneal Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:New AIS Database Tracks All Programs, Plans Serving the Dual-Eligible Community 2Health News:Diet Doc Makes Dieting for People on the Go Easier than ever before with Pre-Packaged Diet Meals, Desserts, Snacks and new Breakfast Omelets 2Health News:Diet Doc Makes Dieting for People on the Go Easier than ever before with Pre-Packaged Diet Meals, Desserts, Snacks and new Breakfast Omelets 3Health News:Diet Doc Makes Dieting for People on the Go Easier than ever before with Pre-Packaged Diet Meals, Desserts, Snacks and new Breakfast Omelets 4Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 2Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 4Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 5Health News:Quarks and Forks at the Science Museum of Virginia 2
... likely to bear an underweight child, but some women ... genetic susceptibility.// The finding could help medicine better determine ... said they were not recommending at this point that ... ,"Our data demonstrate that a subgroup of ...
... the UK’s biggest killer, accounting for one in four ... key issue is that the diversity of lung disease ... have specialists who deal only in one disorder, chest ... obstructive pulmonary disorder(COPD), asthma, pneumonia, cystic fibrosis and sleep ...
... found that butterbur extract is an effective antihistamine without ... contains an active biochemical agent,// otherwise it would not ... might react with other medications. ,It was ... patients either butterbur extract tablets or the usually used ...
... Millions of Americans have been drinking tap water contaminated ... to disinfect drinking water.// When it is added to ... farms or lawns, however, it can form compounds such ... study released by the Environmental Working Group and Public ...
... save 40,000 more lives each year worldwide if more people ... took it, doctors said.// An analysis of nearly 300 ... to prevent blood clots confirmed that aspirin reduces heart attacks ... the people who could benefit from aspirin and anti-platelet therapy ...
... has launched Hyalosyn (sodium hyaluronate), an intra-articular injection that ... suffering from severe osteoarthritis. Osteoarthritis is a widely prevalent ... the age of 45 are estimated to show signs ... of disability in people above the age of 65. ...
Cached Medicine News:
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: